Summary: Parabens (alkyl esters of 4-hydroxybenzoic acid) are widely used as preservatives in drugs, cosmetic products, and foodstuffs. Safety concerns have recently increased due to the potential health risks associated to exposure to large amounts of these substances. Biotransformation of parabens mainly includes hydrolysis of the ester bond and glucuronidation reactions. The hydrolysis and glucuronidation of a series of six parabens differing by the nature of the alkyl group were investigated in human liver microsomes and plasma, and the major human UDP-glucuronosyltransferase (UGT) isoforms involved in the reaction were identified. Methyl-and ethylparaben were stable in human plasma, with 95z of the initial concentration remaining after 24 h. On the other hand, propyl-, butyl-and benzylparaben concentrations decreased by 50z under similar conditions. In contrast, rapid hydrolysis was measured with human liver microsomes depending on the alkyl chain length, with t1/2 varying from 22 min for methylparaben to 87 min for butylparaben. All parabens were actively glucuronidated by liver microsomes, in comparison to 4-hydroxybenzoic acid. They were mainly substrates of human recombinant UGT1A1, UGT1A8, UGT1A9, UGT2B7, UGT2B15 and UGT2B17. In conclusion, the parabens were readily metabolized in human liver through esterase hydrolysis and glucuronidation by several UGT isoforms. These results suggest that these parabens do not accumulate in human tissue.
Introduction
Parabens (alkyl esters of 4-hydroxybenzoic acid) are natural or synthetic compounds that have been extensively used since the 1920s in the cosmetic, pharmaceutical, and food industries for their very effective antimicrobial activity. 1) They differ from each other by the nature of the alkyl moiety (Fig. 1) . Becouse methyl-and propylparaben can be found in plants, a series of parabens with increasing alkyl chain length and presenting improved antimicrobial properties 2) has been prepared chemically at low cost.
Man is daily exposed to these substances from a large array of consumer products, and they are considered to
Fig. 2. Metabolic routes for parabens in man
Parabens are mainly metabolized through hydrolysis supported by esterases and through glucuronidation catalyzed by UDPglucuronosyltransferases (UGT) using UDP-glucuronic acid (UDPGA). They can also produce sulfoconjugates by sulfotransferase (ST) using 3?-phosphoadenosine 5?-phosphosulfate (PAPS) as the sulfate donor substrate, or 4-hydroxyhippuric acid by amino acid transferase (AT) using glycine as the donor substrate. be safe. Several toxicity studies of these compounds have been carried out in animals and in man; no marked toxicity was found as they are rapidly absorbed, metabolized and excreted from the body. 1) However, recent reports indicated that parabens could act as endocrine modulators or disruptors with a moderate estrogenic activity which could lead to possible undesirable effects on human health. Moreover, parabens-containing antiperspirants have been suspected of increasing breast cancer incidence. The detection in small quantities of non-metabolized parabens in human breast tumors 3) may suggest that the substances could accumulate over time in tissues and induce toxic effects. 4, 5) Parabens are extensively metabolized. They are mainly hydrolyzed to 4-hydroxybenzoic acid in mammals, which is thereafter conjugated with sulfate, glucuronide or glycine ( Fig. 2) prior to being excreted in urine. [6] [7] [8] Esterases are efficient in the hydrolysis of parabens to 4-hydroxybenzoic acid. 9, 10) In man, parabens can also be excreted as glucuronides and sulfate conjugates.
1)
The metabolic profile is strongly dependent on the exposure route. Indeed, paraben glucuronides have been used as urinary biomarkers of exposure in man, rather than 4-hydroxybenzoic acid, which is a nonspecific metabolite of all parabens. 11) Glucuronidation reactions are supported by the multi-genic family of enzymes the UDP-glucuronosyltransferases (UGT). 12) They catalyze the binding of glucuronic acid from a high-energy donor, UDP-a-D-glucuronic acid, onto structurally unrelated substances with a nucleophilic acceptor group (hydroxyl, carboxylic acid, thiol or amine) leading to the formation of hydrophilic bglucuronides that are excreted in urine and bile. 13, 14) Up to nineteen UGT isoforms have been identified in humans and are classified into families 1 and 2 based on sequence identity. 15) Cloning of their cDNA and subsequent heterologous expression of the recombinant proteins have revealed distinct but overlapping substrate selectivity.
This study was focused on the in vitro hydrolysis and glucuronidation in plasma and in liver microsomes of a series of six parabens commonly used in the industry. The main UGT isoforms involved in the formation of paraben glucuronides were identified. The impact of the nature of the alkyl group on the metabolism of parabens was also investigated. The results obtained indicated that the parabens are actively hydrolyzed or glucuronidated in liver microsomes by several UGTs belonging to families 1A and 2B.
Methods
Chemicals and materials: 4-Hydroxybenzoic acid, methylparaben, propylparaben, bilirubin, and EDTA were purchased from Himedia (Mumbai, India). Ethylparaben, propylparaben, butylparaben, benzylparaben and octylgallate were obtained from Fluka Biochemika, USA. UDP-[U- 14 C]-glucuronic acid (specific activity 285 mCi/mmol) was purchased from Perkin Elmer (Courtaboeuf, France). UDP-glucuronic acid, maleic acid, 1-naphthol, ketoprofen, 4-nitrophenol, 4-aminobiphenyl, eugenol, hyodeoxycholic acid, phenylmethanesulfonylfluoride (PMSF) and dimethyl sulfoxide were from Sigma Aldrich, (Saint Louis, MO). Trifluoroacetic acid was from Acros Organics (Noisy-le-Grand, France) and methanol from Prolabo HiPerSolv CHROMANORM, (Strasbourg, France). Plasma samples were prepared by centrifugation of citrated venous blood and obtained from healthy adult subjects at Notre Dame de Secours Hospital, (Jbeil, Lebanon).
Enzyme sources: Human serum albumin (essentially fatty acid free) was obtained from Sigma-Aldrich. Human liver microsomes (pool of 21 livers from men and women) were purchased from Biopredic (Rennes, France). The recombinant human UGT isoforms UGT1A1 and UGT1A3 were purchased from InVitrogen, (Illkirch, France), whereas UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9, UGT2B4, UGT2B7, UGT2B15, and UGT2B17 were obtained from BD Biosciences (Le Pont de Claix, France) and used according to the recommendations of the suppliers. All these UGT isoforms were expressed in insect cells (Supersomes) infected with the corresponding UGT gene-inserted baculovirus. The activity of these enzymes was measured using marker substrates: 1-naphthol for UGT1A6, UGT1A7, UGT1A8, and UGT1A9; octylgallate for UGT1A1; 4-nitrophenol for UGT1A3; 4-aminobiphenyl for UGT1A4; hyodeoxycholic acid for UGT2B4; ketoprofen for UGT2B7 and eugenol for UGT2B15 and UGT2B17. Protein concentration was determined by Bradford's method. 16) Stability of parabens in human plasma and liver microsomes: The degradation of parabens into 4-hydroxybenzoic acid was studied at 379 C in 67 mM phosphate buffer (pH 7.4), in human plasma, in albumin solution (580 mM) dissolved in phosphate buffer (pH 7.4), and in human liver microsomes (100 mg) in 100 mM TrisHCl buffer (pH 7.4). The stability study of parabens in human plasma was approved by the Committee on the Ethics of Research in Human Experimentation at the Lebanese University. Informed consent for participation in the study was obtained from all individuals. Plasma samples were prepared by centrifugation of citrated venous blood obtained from healthy male (n＝9) subjects aged between 25 and 35 years at Notre Dame de Secours Hospital, Jbeil, Lebanon. A preliminary analysis of each plasma sample by HPLC was performed to ensure the absence of parabens in these samples. Three pools were prepared: each one was a mixture of three plasma samples. The stability of each paraben was studied separately in each of these three pools.
The concentration of parabens dissolved in dimethyl sulfoxide was maintained at 164 mM in all incubations. At appropriate time intervals (0, 1, 6, 24 h), samples (100 mL) of the reaction medium were taken and analyzed by HPLC 10) modified as described below. The HPLC apparatus (Thermo Finnigan, Saint Jose, CA) consisted of a degasser unit (Spectra System SCM1000), a pump (Spectra system P 2000, Saint Jose, CA) coupled to a C18, 5 mm, 150×4.6 mm (BDS, Thermo, UK), a UV-visible detector (Spectra System UV1000) and a computer workstation. Elution was performed either with a gradient of acetonitrile-tetrahydrofuran-isopropanol (80/80/20, v/v) in water, or in isocratic conditions with methanol, water, and trifluoroacetic acid (50:50:0.05 v/v) at a flow rate of 1 ml/min. Quantitation was carried out from standard curves obtained with increasing amounts of internal standards as follows. Benzylparaben was the internal standard for the assay of methylparaben, propylparaben for the assay of ethylparaben, ethylparaben for the assays of propylparaben and butylparaben, and methylparaben in the assay of benzylparaben. The method was validated in terms of linearity, repeatability and limit of detection. Calibration curves were constructed by plotting the paraben/standard paraben area ratio against the concentration of paraben in mg/mL, and the linear relationships were evaluated by regression analysis with the least-squares method. The equations were drawn from eight concentrations and the experiments were repeated six times. The lower limits of detection were 250, 170, 300, 500 and 550 ng/ml, respectively, in the assays of methyl-, ethyl-, propyl-, butyl-and benzylparaben. Linearity of each assay was obtained in the concentration range 1-100 mg/mL. The values of the intercept on ordinates were close to zero. The correlation coefficients ranged from 0.96 to 0.9996 (n＝6). The RSD values were lower than 5%.
The same experiment was repeated in human liver microsomes in similar conditions to those described above. The reaction was terminated by adding one volume of acetonitrile:methanol:trifluoroacetic acid (49.6:49.6:0.8 v/v) after 0, 10, 20, 30, 40 and 60 min, and 100-mL samples of the medium were withdrawn in order to determine the kinetic profile for hydrolysis of the substrates. The assays were repeated three times. The first-order rate constants (K) were calculated during the first 60 min of incubation from the slopes of linear plots of the logarithm of the percentages of paraben remaining against time. The corresponding half-life was obtained from the equation: t1/2＝0.693/K. Triplicate samples were analyzed, and the mean value of the rate constant was calculated.
Glucuronidation assay: Glucuronidation of paraben and 4-hydroxybenzoic acid by human liver microsomes and recombinant UGT was performed by a modified method of Bansal and Gessner. 17) Briefly, enzyme proteins (50 mg of protein) were added to the reaction medium (final volume of 40 ml) composed of 100 mM Tris-HCl (pH 7.4), 10 mM MgCl2 [or 50 mM TrisMaleate (pH 6.5), 5 mM MgCl2] and 1 mM paraben or 4-hydroxybenzoic acid dissolved in dimethyl sulfoxide. The reaction was initiated by the addition of 0.1 mM UDPglucuronic acid and UDP-[U-14 C]-glucuronic acid (250,000 cpm) and was performed at 379 C for 1 h. A control was simultaneously run using dimethyl sulfoxide instead of the parabens. Assays were also run in the presence of 1 mM PMSF, a serine protease inhibitor that inhibits the carboxylesterase activity. 19, 20) Every assay was repeated twice. The reaction was terminated by the addition of ice-cold ethanol (40 ml). After centrifugation of the reaction mixture at 3,000×g, an aliquot (60 ml) of the supernatant fraction was applied to an LK6DF silica gel-coated thin-layer chromatography plate (Whatman, Schleicher & Schuell, Montluçon, France) and then developed with a solution containing n-butanol, acetone, acetic acid, aqueous 28% (v/v) ammoniac, and water (35:25:9:0.75:30 v/v). After separation by thin-layer chromatography, the plate was dried for 2 h and then put in contact with Kodak BioMax MR Film (Sigma Aldrich) and stored in the dark for at least two days at -209 C. The glucuronides were spotted on the plate, the corresponding gel zone was scraped, and the radioactivity associated was measured with a Packard spectrometer, using Fluoran Safe Ultima Gold (Courtaboeuf, France) as the scintillation cocktail.
Statistical evaluation of the effect of PMSF on glucuronidation of parabens was performed using STAT-VIEW 1992-98 software.
Identification of the structure of paraben glucuronide: The structure of the glucuronide formed was established by LC-MS using benzylparaben as the model substrate. Glucuronide was produced by incubation of 3 mM benzylparaben in the presence or absence of 1 mM PMSF with 100 mg of human liver microsomes or 20 mg of UGT1A9, 5 mM UDP-glucuronic acid, 5 mM saccharolactone, 100 mM Tris-HCl (pH 7.4) and 10 mM MgCl2 in a final volume of 200 ml for 1 and 2 h at 379 C. A control was performed without UDPglucuronic acid. The reactions were terminated by addition of 20 ml 6 M HCl and the reaction mixtures were centrifuged at 8,000×g to remove proteins; the supernatant was processed by HPLC.
The supernatant (20 ml) resulting from the incubation described above was injected in HPLC apparatus which consisted of a U3000 (DIONEX) coupled to an ESI-Qq-TOF high-resolution mass spectrometer (Bruker, Wissembourg, France). The HPLC apparatus was equipped with an XBridge C18 column (5 mm, 4.6 mm×150 mm; Milford, MA). The mobile phase consisted of methanol, water, and trifluoroacetic acid (50:50:0.05 v/v), and isocratic elution was carried out at a flow rate of 1 ml/min. The cone voltage of the ESI-Qq-TOF was set at 4500 V and the temperature of the source was 1909 C. Data were collected by MicroTOFControl software and analyzed by DataAnaysis using Bruker software (version 3.4).
Kinetic studies: Apparent kinetic constants, Km and Vmax, for glucuronidation of parabens and 4-hydroxybenzoic acid were determined using SigmaPlot 9.0 2004 software by varying the concentration of the acceptor substrates (0.05 to 10 mM) with a constant concentration of UDP-glucuronic acid (5.0 mM). Incubation assay conditions were selected to insure linearity of the reaction versus time and enzyme concentration. When liver microsomes were used, kinetics were performed with or without PMSF (1.0 mM).
Results
Stability of parabens in human plasma, albumin solution and liver microsomes: Parabens were completely stable in buffer at pH 7.4. None of them showed any disappearance even after 24 h of incubation at 379 C (data not shown). A preliminary analysis of the human plasma by HPLC was performed to ensure the absence of parabens in the samples. Stability of parabens in human plasma depended on the structure of the side chain. Methylparaben and ethylparaben were almost completely Hydrolysis rate constants (K) and half lives (t 1/2 ) of parabens in 67 mM phosphate buffer saline (pH 7.4) and with human liver microsomes calculated during the first 60 min of incubation. Constants are calculated from data presented in Figure 4 .
stable. After 24 h of incubation, the residual methylparaben and ethylparaben concentrations represented, respectively, 95% and 94.4% of the initial methylparaben and ethylparaben concentrations in human plasma (Fig.  3) . Although propylparaben was stable in the first 6 h of incubation in human plasma (Fig. 3) , the residual propylparaben concentration represented 47.0±5.0% of the initial concentration in human plasma after 24 h of incubation. In contrast, disappearances of butylparaben and benzylparaben were detected after the first hour of incubation ( Fig. 3) and were time-dependent, leading to a roughly 50% decrease in concentration after 24 h. The stability of each paraben was studied also in albumin solution (580 mM) at pH 7.4. HPLC analysis of aliquots taken from mixtures at 1 and 6 h showed that the parabens were not hydrolyzed. After 24 h of incubation, less than 15% of the initial paraben concentrations had disappeared (data not shown).
The hydrolysis of parabens in human liver microsomes occurred more rapidly than in plasma, and the rate decreased as a function of the chain length (Fig. 4) . The hydrolysis rate followed first-order kinetics, thus allowing the determination of hydrolysis rate constants and half-lives. The half-lives varied from 22 min for methylparaben to 87 min for butylparaben ( Table 1) ; benzylparaben was hydrolyzed at an intermediate rate, with a half-life of 43 min.
Identification of benzylparaben glucuronides by liquid chromatography-mass spectrometry: Figure 5 shows a typical electrospray spectrum in the positive ion mode obtained with benzylparaben glucuronide formed by human liver microsomes. Pseudomolecular ions were observed at m/z 91.05, 251.07, 267.09 and 427.10 and were attributed to toluene, benzylparaben (sodium salt), phenyl-glucuronate and benzylparaben glucuronide (sodium salt), respectively. The same glucuronide spectrum was obtained after the incubation of the medium in the presence of PMSF. The results indicated the formation of a benzylparaben-4-Oglucuronide.
Glucuronidation of 4-hydroxybenzoic acid and parabens by human liver microsomes and recombinant human UGT isoforms: In order to identify the UGT isoforms that catalyze the glucuronidation reaction, 4-hydroxybenzoic acid and a series of parabens were incubated with 12 human UGTs, including 8 UGT1A subfamily and 4 UGT2B subfamily isoforms in 100 mM Tris-HCl (pH 7.4) and 10 mM MgCl2 (Fig. 6) . The functionality of the recombinant proteins was previously checked with marker substrates. As judged by glucuronidation activity, UGT1A1, UGT1A8, UGT1A9, UGT2B7, UGT2B15, and UGT2B17 showed higher capacities than the other UGT isoforms examined (Fig.  6 ). UGT1A8 and UGT1A1 showed higher activity toward the benzylparaben than the other parabens with an aliphatic chain, whereas UGT1A9, UGT2B7, UGT2B15, and UGT2B17 showed a lesser or similar activity toward benzylparaben (Fig. 6) . Finally, UGT1A3, UGT1A4 and UGT1A10 showed a very low activity.
Effect of phenylmethanesulfonylfluoride on the glucuronidation of parabens: Parabens are esters of 4-hydroxybenzoic acid which can be hydrolyzed by esterases prior to glucuronidation. As carboxylesterases are present in human liver microsomes, 10) we studied the influence of PMSF (1.0 mM), a strong serine protease inhibitor of carboxylesterase, 18) on paraben glucuronidation. As expected, glucuronidation of 1-naphthol was not affected (Fig. 7) . 4-Hydroxybenzoic acid and methyl-, propyl-and butylparaben glucuronidations were not significantly affected by PMSF; however, ethyl-and benzylparaben glucuronidation activities significantly increased by 59.2% and 140.7%, respectively in the presence of PMSF (Fig. 7) .
Similar experiments were performed with UGT1A9. Addition of PMSF did not significantly change or even slightly decrease the glucuronidation activity (results not shown). These results indicate the absence of esterase activity in the recombinant enzyme preparation.
Kinetics of paraben glucuronidation by human liver microsomes and by recombinant UGT1A9: Kinetic analysis was performed for glucuronidation of parabens by human liver microsomes in the absence or presence of 1 mM PMSF. Representative plots of glucuronidation rate versus substrate concentration showed typical Michaelis-Menten kinetics (data not shown), which led to the calculation of the apparent kinetic constants Km and Vmax ( Table 2) . However, 4-hydroxybenzoic acid is a very poor substrate of microsomal or recombinant UGTs compared to parabens; this fact was evident when 4-hydroxybenzoic acid failed to reach saturating conditions, even with high concentrations (10 mM), thus leading to uncertainty in the determination of its kinetic constants. The large error bar measured from repeated determinations underlines the difficulty in determining this parameter due to the very low velocity measured ( Table 2) . On the other hand, substrate inhibition was observed for 10 mM parabens, except for methylparaben (results not shown).
The affinity of enzyme fractions toward parabens was much higher than that measured with 4-hydroxybenzoic acid. On the other hand, Km values decreased with benzylparaben which has the bullkiest structure. Inhibition of the esterase activity by PMSF did not change the Km constants for parabens ( Table 2) .
Kinetic analysis was also performed on UGT1A9 as a model enzyme catalyzing the glucuronidation of parabens. The reaction was performed without PMSF, as addition of the inhibitor did not significantly change the glucuronidation rate. Here also, affinity toward 4-hydroxybenzoic acid was low when compared to the series of parabens.
Discussion
Parabens are largely used as preservatives in cosmetics, drugs and foodstuffs due to their efficient antibacterial properties. Potential health risks in man as a result of regular exposure have recently been suggested, although these substances have been considered safe because their extensive metabolism prevents them from accumulating in tissues. The possible estrogenic hazard of parabens is still a much-debated question. Such a hazard may, however, be affected by the metabolism and elimination rates of these substances, which are dose, route and species dependent. 1, 4, 21) The aim of this work was to better characterize the in vitro biotransformation in man of a series of parabens commonly used in industry. Attention was paid to the hydrolysis and glucuronidation reactions, which are the main metabolic pathways in man. These processes are catalyzed by the multifamilies of esterases and UGTs. In particular, the contribution of UGT isoenzymes has never been assessed. Surprisingly, parabens were rather stable in plasma, especially methyl-and ethylparaben. Hydrolysis accounted for 50% of the initial dose, however, for the other compounds after one day. Our results were consistent with those of Ye et al., 25) who reported that methylparaben was stable in human plasma, even after 30 days. On the other hand, they also found that propylparaben was stable in similar conditions. This result was different from our study, in which propylparaben was found to be 50% hydrolyzed after one day (Fig. 3) , suggesting the importance of inter-individual esterase activity variation in the hydrolysis of these compounds in humans.
Human plasma contains many esterases, such as butyrylcholinesterase, paraoxonase, acetylcholinesterase and albumin, 22, 23) that can be involved in paraben hydrolysis. We found, however, that albumin, which is known to possess esterase activity, 24) was not involved in the hydrolysis of the series of parabens at physiological concentration (580 mM).
In contrast to the situation in plasma, parabens were not stable in human liver microsomes. They were rapidly hydrolyzed, but their hydrolysis rate constants decreased linearly according to the length of the alkyl chain when human liver microsomes were used. Butylparaben was 4-times less rapidly hydrolyzed than methylparaben. The introduction of a benzyl ring found in benzylparaben did not enhance the stability compared to that of the other compounds. The results obtained were in accordance with those reported by Jewell et al., 10) except those for benzylparaben, whose hydrolysis rate they found to be similar to that measured for butylparaben, but with high inter-individual variations. These authors 9, 10) showed that parabens were mainly hydrolyzed to 4-hydroxybenzoic acid by microsomal carboxylesterases 1 and 2.
In liver microsomes, hydrolysis competed with glucuronidation for the metabolism of parabens. PMSF noticeably inhibits human liver microsomal carboxylesterase activities, which are involved in xenobiotic hydrolysis. 19, 20) The addition of PMSF to liver microsomes showed that the inhibitor was able to modulate the glucuronidation activity of two parabens. It did not affect 4-hydroxybenzoic acid, methyl-, propyl-and butylparaben glucuronidation, whereas, it increased the glucuronidation of ethyl-and benzylparaben. Table 2 shows that there is a decrease in Km values for ethyl-and benzylparabens in the presence of PMSF. This result indicates that the affinity of human liver microsomes for these two compounds increased in the presence of PMSF. This can explain the significant increase of glucuronidation rate of these two parabens in the presence of PMSF in Figure 7 .
The data also suggest that the formation of the 4-Oglucuronide of parabens accounted for most of the glucuronidation activity measured, as 4-hydroxybenzoic acid resulting from the hydrolysis was glucuronidated at a very low rate and presented a Km value about 5 times higher than that measured for the parabens. On the other hand, incubation performed at pH 6.5 in maleate buffer, which is known to increase the stability of acylglucuronides formed, 24) did not enhance the production of 4-hydroxybenzoic acid glucuronides (not shown). Indeed, the LC-MS experiment clearly identified the biosynthesis of an ether 4-hydroxyglucuronide after incubation with human liver microsomes.
We next determined the human UGT1A and UGT2B isoforms able to glucuronidate parabens. Parabens were substrates of both UGT1A and UGT2B families, among those, UGT1A1, UGT1A8, UGT1A9, UGT2B7, UGT2B15 and UGT2B17 were the most efficient. UGT1A9 is one of the major isoforms in liver that metabolizes a wide array of substances, e.g., drugs, steroids, bile acids, fatty acids, and dietary constituents. Radominska-Pandya et al., 13) reported that substituted phenols, such as 4-ethyl, 4-butyl, and 4-pentylphenols, whose structures are comparable to those of parabens were glucuronidated by UGT1A9. UGT1A8 and UGT1A1, which also compete with UGT1A9 toward phenolic substances, 26, 27) could also glucuronidate parabens. On the other hand, UGT1A6, which is known to metabolize planar phenolic substances such as naphthols or polycyclic aromatic hydrocarbons, 28, 29) was poorly active with parabens, thus indicating that the bulkiness of the alkyl/benzyl moiety strongly affected the glucuronidation rate by this isoform. UGT2B isoforms as UGT2B7, UGT2B15 and UGT2B17 were also able to catalyze the glucuronidation of parabens. The multiplicity of the UGT isoforms involved in the biotransformation of parabens constitutes a powerful detoxification barrier. This overlapping substrate specificity may efficiently counteract the possible changes in UGT specific isoform activity due to genetic polymorphism or induction/repression after drug exposure, thus suggesting that these compounds may be considered as safe molecules in humans.
Apparent Km values measured with UGT1A9 for ethyl-, propyl-and benzylparaben were similar to those found with human liver microsomes, thus suggesting this isoform was one of the main UGTs responsible for glucuronidation of these substances. Examination of the apparent Km and Vmax/Km values in liver microsomes revealed that the enzyme efficiency increased for the bulkier substance, benzylparaben. This was probably due to a concomitant increase in lipophilicity of this compound in regard to the hydrophobic microsomal membrane environment of the UGT binding site. 30, 31) In conclusion, this study shows that parabens are extensively metabolized in human liver microsomes by the combined action of esterases and UGT of families 1A and 2B. Compared to 4-hydroxybenzoic acid, parabens were good substrates of UGT. Altogether, this active biotrans-formation is likely to prevent the accumulation of these molecules in man and thus prevent their possible toxicity.
